Jan Kaiserle

Imagine a world where a doctor’s visit is just a click away, no matter where a patient resides or what time of day it is—telehealth has turned this vision into reality for millions across the globe, reshaping how medical services are accessed. This transformative approach breaks down barriers of

What happens when the building blocks of life face destruction before they can fulfill their purpose, and how do cells protect these vital components during such a delicate process? Inside every cell, a precise mechanism unfolds where proteins, essential for everything from immunity to growth, are

As the global scientific community pushes the boundaries of genetic research and biotechnology, the demand for specialized tools like Drosophila bottles—containers designed to house fruit flies for experimental studies—has surged dramatically on the path to 2026. These seemingly modest lab

Spinal Muscular Atrophy (SMA), a rare genetic disorder that causes progressive muscle weakness and significant life challenges, has long been a focus of medical research seeking transformative solutions for affected individuals across all ages. A pivotal moment in this journey arrived on November

In an era where technology intersects with the most critical aspects of human life, the realm of medical artificial intelligence (AI) is experiencing a seismic shift, moving decisively from a fascination with visual sophistication to an unwavering commitment to reliability and precision in clinical

In a world where medical advancements have conquered countless diseases, a silent yet deadly threat looms large—drug-resistant fungal infections are claiming millions of lives each year, often with little public attention. These infections strike hardest at the most vulnerable, such as cancer

Could a tiny, often overlooked component of the immune system hold the answer to saving the pork industry from a billion-dollar scourge? Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) devastates pig herds worldwide, slashing productivity and straining farm economies with staggering

In a groundbreaking moment for the biotechnology sector, San Diego-based startup Iambic has captured the spotlight by raising an impressive $100 million in Series B financing to propel clinical trials of its AI-discovered cancer drugs, marking a significant milestone for the company. This

Glioblastoma, recognized as the most aggressive and common form of brain cancer, especially in its IDH wild-type variant, remains a daunting challenge with survival rates often limited to about a year despite intensive treatments like surgery, radiotherapy, and chemotherapy. A groundbreaking study

In the heart of Omaha, Nebraska, the University of Nebraska Medical Center (UNMC) is quietly transforming the landscape of cancer treatment through its pioneering work in precision oncology, proving that geographic location is no barrier to innovation. Far from the bustling medical hubs of the East